³Ô¹ÏÍøÕ¾

Latest

Latest CSL News

  • Latest CSL news stories and updates. What is happening today? All recent CSL news and developments. Live coverage and timeline of CSL. All you need to know about CSL.
Investigations into lung cancer and into epigenetics recognised with 2 x $1.25 million CSL Centenary Fellowships
Pharmanovia Acquires Exclusive Rights to Treatment for Parkinson’s Disease
Innovation and industry leaders appointed to STA’s Bench-to-Boardroom Committee
CSL announces sale of Wuhan plasma collection and fractionation operations
AusBiotech 2024 ³Ô¹ÏÍøÕ¾ Conference Programme Unveiled
Jackie Fairley Appointed To Baker Institute Board
CSL Reports Strong Profit Growth For Full Year 2024
Fast Five With Jon Cross
Lupus is more common and severe in Aboriginal and Torres Strait Islander peoples. Learning why is crucial
Bird flu isn’t spreading in humans for now. But there are vaccines in the pipeline if that changes
Dr James Campbell Appointed AusBiotech Chair
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe
AusBiotech and BIO partner to deliver ‘Investing in Australia’ Roundtable at BIO 2024
Supporting Our Nearest Neighbours Through Antivenom Partnership
First approved treatment for people living with moderate-to-severe itch (pruritus) associated with chronic kidney disease added to the PBS
AECOM appoints Heidi Sick to lead its energy and environment team in Australia and New Zealand
UniSC helping to determine next flu vaccine for Southern Hemisphere
Cell & Gene Catalyst submits feedback on HTA consultation
Australian Institute for Infectious Disease (AIID) announces early works contractor
Jobs Boost As World-Leading Company Makes Parkville ³Ô¹ÏÍøÕ¾
Targeting inflammatory protein could help treat severe asthma
Intravenous iron treatment Ferinject® (ferric carboxymaltose) now approved for Australian children aged one to thirteen years living with iron deficiency anaemia
CSL reports strong first half growth with immunoglobulins the highlight
Cell & Gene Catalyst working groups members announced
Year of collective success: 2023 in review
AusBiotech energised by new Board appointments
Australia’s Cell and Gene Catalyst calls for Expressions of Interest
Victorian manufacturing industry on show
New survey shows significant gaps in Australians understanding of Iron Deficiency
Successful clinical trial for re-engineered UQ vaccine
Victoria’s Consular Corps visit Monash, scientists showcase latest innovations
AusBiotech Board election result announced
We could see thunderstorm asthma in south-eastern Australia this season – here’s how to prepare
Australia’s most sustainable tapware company wins big at local awards
New approaches to blood and liver cancer therapies recognised with $2.5 million CSL Centenary Fellowships
CSL announces seven new Global Research Acceleration Initiative projects
Director appointed to Australia’s Cell and Gene Catalyst
Novel therapeutics development highlighted in Australasian Biotechnology journal
Save $350 with AusBiotech 2023 early-bird rates
AusBiotech 2023 programme launched
CSL reports strong profit growth with record plasma collections
AusBiotech 2023 Millis Orator announced
New precision identifies microbiome keys to IBD
ACDC funding to power up coronary artery disease research
The new ‘Jumar Bioincubator’ calls for biotechnology start-ups
TGA approves pathway for more plasma donors
Lifeblood sexual activity and PrEP deferrals
Expert comment: will Twitter’s appointment of a female CEO pave the way for females in big tech?

© 2024 - ³Ô¹ÏÍøÕ¾